지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.1
- 수록면
- 159 - 172 (14page)
이용수
초록· 키워드
오류제보하기
Less than one third of patients who suffer from major depressive disorder (MDD) report remission following antidepressant treatments requiring more diverse treatment approaches. Augmentation of second generation antipsychotics (SGAs) has been increasingly recognized as an important treatment option. The authors have previously provided a comprehensive review of SGAs for the treatment of MDD in 2013. Since then, numerous additional clinical trials have been conducted to investigate diverse issues regarding the utility of SGAs in MDD. Moreover, a new SGA, brexpiprazole, was recently approved by the Food and Drug Administration in July 2015 for the treatment of MDD as an augmentation agent to antidepressants. Thus, the aim of this study was to provide a concise update of all the available SGAs for the treatment of MDD, in particular on the additional clinical trials which have been published since 2013.
목차
등록된 정보가 없습니다.
참고문헌 (88)
참고문헌 신청
Pae CU / 2009 / Atypical depression: a comprehensive review / CNS Drugs 23:1023~1037
Kulkarni SK / 2009 / Current investigational drugs for major depression / Expert Opin Investig Drugs 18:767~788
Rush AJ / 2006 / Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report / Am J Psychiatry 163:1905~1917
Wang SM / 2015 / Criticisms of drugs in early development for the treatment of depression: what can be improved? / Expert Opin Investig Drugs 24:445~453
Shelton RC / 2001 / A novel augmentation strategy for treating resistant major depression / Am J Psychiatry 158:131~134
Kulkarni SK / 2009 / Current investigational drugs for major depression / Expert Opin Investig Drugs 18:767~788
Rush AJ / 2006 / Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report / Am J Psychiatry 163:1905~1917
Wang SM / 2015 / Criticisms of drugs in early development for the treatment of depression: what can be improved? / Expert Opin Investig Drugs 24:445~453
Shelton RC / 2001 / A novel augmentation strategy for treating resistant major depression / Am J Psychiatry 158:131~134
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
PSYCHIATRY INVESTIGATION
2016 .01
-
Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
PSYCHIATRY INVESTIGATION
2020 .01
-
Diagnostic Issues of Depressive Disorders from Kraepelinian Dualism to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
PSYCHIATRY INVESTIGATION
2019 .01
-
성인 아토피 피부염 환자의 우울증 동반에 따른 점증적 비용 부담: 후향적 단면연구
보건의료기술평가
2021 .12
-
BeMicroarray Analysis of the Major Depressive Disorder mRNA Profile Data
PSYCHIATRY INVESTIGATION
2015 .01
-
Gender Differences in Depressive Symptom Profile: Results from Nationwide General Population Surveys in Korea
Journal of Korean Medical Science
2015 .01
-
Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
2023 .05
-
Bidirectional Association between First-Episode Panic Disorder and Major Depressive Disorder in a Nationwide General Population Survey in Korea
Journal of Korean Medical Science
2019 .01
-
Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
2018 .01
-
Comparison of Electroencephalography (EEG) Coherence between Major Depressive Disorder (MDD) without Comorbidity and MDD Comorbid with Internet Gaming Disorder
Journal of Korean Medical Science
2017 .01
-
Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
PSYCHIATRY INVESTIGATION
2020 .01
-
Expected Emotional Usefulness and Emotional Preference in Individuals with Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
2016 .01
-
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Comparison of Autonomic Reactivity to the Stress between Adjustment Disorder and Major Depressive Disorder
PSYCHIATRY INVESTIGATION
2020 .01
-
Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment
PSYCHIATRY INVESTIGATION
2016 .01
-
Reduced Temporal Activation During a Verbal Fluency Task is Associated with Poor Motor Speed in Patients with Major Depressive Disorder
PSYCHIATRY INVESTIGATION
2020 .01
-
The Relationship of Lifestyle Factors with the Prevalence of Major Depressive Disorder by Ecological Factors
PSYCHIATRY INVESTIGATION
2021 .01
-
주요우울장애를 동반한 공황장애 환자군의 임상적 특징
생물정신의학
2018 .01
-
A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
Clinical Psychopharmacology and Neuroscience
2018 .01
-
Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
PSYCHIATRY INVESTIGATION
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0